These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 36705564)

  • 1. Regulatory T cells suppress the formation of potent KLRK1 and IL-7R expressing effector CD8 T cells by limiting IL-2.
    Tsyklauri O; Chadimova T; Niederlova V; Kovarova J; Michalik J; Malatova I; Janusova S; Ivashchenko O; Rossez H; Drobek A; Vecerova H; Galati V; Kovar M; Stepanek O
    Elife; 2023 Jan; 12():. PubMed ID: 36705564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced suppression of polyclonal CD8
    Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
    J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T-cell-derived interleukin-15 shapes cytotoxic T cell memory.
    Geginat J; Granucci F
    Eur J Immunol; 2023 Jan; 53(1):e2250238. PubMed ID: 36398486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell-derived tissue-associated regulatory T cells suppress the activity of pathogenic cells in autoimmune diabetes.
    Haque M; Lei F; Xiong X; Das JK; Ren X; Fang D; Salek-Ardakani S; Yang JM; Song J
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30777937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of allograft rejection by CD8+CD122+PD-1+ Tregs is dictated by their Fas ligand-initiated killing of effector T cells versus Fas-mediated own apoptosis.
    Liu H; Wang Y; Zeng Q; Zeng YQ; Liang CL; Qiu F; Nie H; Dai Z
    Oncotarget; 2017 Apr; 8(15):24187-24195. PubMed ID: 28445940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. <Editors' Choice> Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity.
    Kochin V; Nishikawa H
    Nagoya J Med Sci; 2019 Feb; 81(1):1-18. PubMed ID: 30962651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Diabetogenic Immunity by IL-15-Activated Regulatory CD8 T Cells in Type 1 Diabetes.
    Stocks BT; Wilson CS; Marshall AF; Hoopes EM; Moore DJ
    J Immunol; 2019 Jul; 203(1):158-166. PubMed ID: 31127035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of IL-2 and IL-4 signals coordinates divergent regulatory T cell responses and drives therapeutic efficacy.
    Zhou JY; Alvarez CA; Cobb BA
    Elife; 2021 Feb; 10():. PubMed ID: 33617447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes.
    Jaberi-Douraki M; Pietropaolo M; Khadra A
    J Theor Biol; 2015 Oct; 383():93-105. PubMed ID: 26271890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
    Peterson LB; Bell CJM; Howlett SK; Pekalski ML; Brady K; Hinton H; Sauter D; Todd JA; Umana P; Ast O; Waldhauer I; Freimoser-Grundschober A; Moessner E; Klein C; Hosse RJ; Wicker LS
    J Autoimmun; 2018 Dec; 95():1-14. PubMed ID: 30446251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organism.
    Ptacin JL; Ma L; Caffaro CE; Acuff NV; Germar K; Severy P; Qu Y; Vela JL; Cai X; San Jose KM; Aerni HR; Chen DB; Esche E; Ismaili TK; Herman R; Pavlova Y; Pena MJ; Nguyen J; Koriazova LK; Shawver LK; Joseph IB; Mooney J; Peakman M; Milla ME
    Commun Med (Lond); 2024 Mar; 4(1):58. PubMed ID: 38532017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-5 promotes induction of antigen-specific CD4+CD25+ T regulatory cells that suppress autoimmunity.
    Tran GT; Hodgkinson SJ; Carter NM; Verma ND; Plain KM; Boyd R; Robinson CM; Nomura M; Killingsworth M; Hall BM
    Blood; 2012 May; 119(19):4441-50. PubMed ID: 22310911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How GRAIL controls Treg function to maintain self-tolerance.
    Fathman CG; Yip L; Gómez-Martín D; Yu M; Seroogy CM; Hurt CR; Lin JT; Jenks JA; Nadeau KC; Soares L
    Front Immunol; 2022; 13():1046631. PubMed ID: 36569931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2-driven CD8
    Niederlova V; Tsyklauri O; Kovar M; Stepanek O
    Trends Immunol; 2023 Nov; 44(11):890-901. PubMed ID: 37827864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-infiltrating mast cells stimulate ICOS
    Lv Y; Tian W; Teng Y; Wang P; Zhao Y; Li Z; Tang S; Chen W; Xie R; Lü M; Zhuang Y
    J Adv Res; 2024 Mar; 57():149-162. PubMed ID: 37086778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes.
    Dong S; Hiam-Galvez KJ; Mowery CT; Herold KC; Gitelman SE; Esensten JH; Liu W; Lares AP; Leinbach AS; Lee M; Nguyen V; Tamaki SJ; Tamaki W; Tamaki CM; Mehdizadeh M; Putnam AL; Spitzer MH; Ye CJ; Tang Q; Bluestone JA
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34324441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
    Kishimoto TK; Fournier M; Michaud A; Rizzo G; Roy C; Capela T; Nukolova N; Li N; Doyle L; Fu FN; VanDyke D; Traber PG; Spangler JB; Leung SS; Ilyinskii PO
    J Autoimmun; 2023 Nov; 140():103125. PubMed ID: 37844543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad induction of immunoregulatory mechanisms after a short course of anti-IL-7Rα antibodies in NOD mice.
    Vazquez-Mateo C; Collins J; Fleury M; Dooms H
    BMC Immunol; 2017 Mar; 18(1):18. PubMed ID: 28356069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.
    Huang W; Kachapati K; Adams D; Wu Y; Leung PS; Yang GX; Zhang W; Ansari AA; Flavell RA; Gershwin ME; Ridgway WM
    J Autoimmun; 2014 May; 50():123-34. PubMed ID: 24556277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD8+ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice.
    Bézie S; Charreau B; Vimond N; Lasselin J; Gérard N; Nerrière-Daguin V; Bellier-Waast F; Duteille F; Anegon I; Guillonneau C
    Blood Adv; 2019 Nov; 3(22):3522-3538. PubMed ID: 31730699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.